1-[4-[10-(2,5-diphenylphenyl)anthracen-9-yl]phenyl]-2-phenylbenzimidazole;1-[4-[10-(3,4-diphenylphenyl)anthracen-9-yl]phenyl]-2-phenylbenzimidazole;2-phenyl-1-[4-[10-(4-pyridin-3-ylphenyl)anthracen-9-yl]phenyl]benzimidazole;2-phenyl-1-[4-[10-(4-pyridin-4-ylphenyl)anthracen-9-yl]phenyl]benzimidazole

C190H126N10 — CID 158150561

About 1-[4-[10-(2,5-diphenylphenyl)anthracen-9-yl]phenyl]-2-phenylbenzimidazole;1-[4-[10-(3,4-diphenylphenyl)anthracen-9-yl]phenyl]-2-phenylbenzimidazole;2-phenyl-1-[4-[10-(4-pyridin-3-ylphenyl)anthracen-9-yl]phenyl]benzimidazole;2-phenyl-1-[4-[10-(4-pyridin-4-ylphenyl)anthracen-9-yl]phenyl]benzimidazole

1-[4-[10-(2,5-diphenylphenyl)anthracen-9-yl]phenyl]-2-phenylbenzimidazole;1-[4-[10-(3,4-diphenylphenyl)anthracen-9-yl]phenyl]-2-phenylbenzimidazole;2-phenyl-1-[4-[10-(4-pyridin-3-ylphenyl)anthracen-9-yl]phenyl]benzimidazole;2-phenyl-1-[4-[10-(4-pyridin-4-ylphenyl)anthracen-9-yl]phenyl]benzimidazole (PubChem CID 158150561) has the molecular formula C190H126N10 and a molecular weight of 2549.17 g/mol. Its IUPAC name is 1-[4-[10-(2,5-diphenylphenyl)anthracen-9-yl]phenyl]-2-phenylbenzimidazole;1-[4-[10-(3,4-diphenylphenyl)anthracen-9-yl]phenyl]-2-phenylbenzimidazole;2-phenyl-1-[4-[10-(4-pyridin-3-ylphenyl)anthracen-9-yl]phenyl]benzimidazole;2-phenyl-1-[4-[10-(4-pyridin-4-ylphenyl)anthracen-9-yl]phenyl]benzimidazole.

Molecular Properties

• Compound Name: 1-[4-[10-(2,5-diphenylphenyl)anthracen-9-yl]phenyl]-2-phenylbenzimidazole;1-[4-[10-(3,4-diphenylphenyl)anthracen-9-yl]phenyl]-2-phenylbenzimidazole;2-phenyl-1-[4-[10-(4-pyridin-3-ylphenyl)anthracen-9-yl]phenyl]benzimidazole;2-phenyl-1-[4-[10-(4-pyridin-4-ylphenyl)anthracen-9-yl]phenyl]benzimidazole
• PubChem CID: 158150561
• Molecular Formula: C190H126N10
• Molecular Weight: 2549.17 g/mol
• Exact Mass: 2547.02
• IUPAC Name: 1-[4-[10-(2,5-diphenylphenyl)anthracen-9-yl]phenyl]-2-phenylbenzimidazole;1-[4-[10-(3,4-diphenylphenyl)anthracen-9-yl]phenyl]-2-phenylbenzimidazole;2-phenyl-1-[4-[10-(4-pyridin-3-ylphenyl)anthracen-9-yl]phenyl]benzimidazole;2-phenyl-1-[4-[10-(4-pyridin-4-ylphenyl)anthracen-9-yl]phenyl]benzimidazole
• SMILES: c1ccc(-c2ccc(-c3c4ccccc4c(-c4ccc(-n5c(-c6ccccc6)nc6ccccc65)cc4)c4ccccc34)cc2-c2ccccc2)cc1.c1ccc(-c2ccc(-c3ccccc3)c(-c3c4ccccc4c(-c4ccc(-n5c(-c6ccccc6)nc6ccccc65)cc4)c4ccccc34)c2)cc1.c1ccc(-c2nc3ccccc3n2-c2ccc(-c3c4ccccc4c(-c4ccc(-c5cccnc5)cc4)c4ccccc34)cc2)cc1.c1ccc(-c2nc3ccccc3n2-c2ccc(-c3c4ccccc4c(-c4ccc(-c5ccncc5)cc4)c4ccccc34)cc2)cc1
• InChI: InChI=1S/2C51H34N2.2C44H29N3/c1-4-16-35(17-5-1)41-33-30-39(34-46(41)36-18-6-2-7-19-36)50-44-24-12-10-22-42(44)49(43-23-11-13-25-45(43)50)37-28-31-40(32-29-37)53-48-27-15-14-26-47(48)52-51(53)38-20-8-3-9-21-38;1-4-16-35(17-5-1)39-30-33-41(36-18-6-2-7-19-36)46(34-39)50-44-24-12-10-22-42(44)49(43-23-11-13-25-45(43)50)37-28-31-40(32-29-37)53-48-27-15-14-26-47(48)52-51(53)38-20-8-3-9-21-38;1-2-11-33(12-3-1)44-46-40-18-8-9-19-41(40)47(44)35-26-24-32(25-27-35)43-38-16-6-4-14-36(38)42(37-15-5-7-17-39(37)43)31-22-20-30(21-23-31)34-13-10-28-45-29-34;1-2-10-34(11-3-1)44-46-40-16-8-9-17-41(40)47(44)35-24-22-33(23-25-35)43-38-14-6-4-12-36(38)42(37-13-5-7-15-39(37)43)32-20-18-30(19-21-32)31-26-28-45-29-27-31/h2*1-34H;2*1-29H
• InChIKey: FVBALGVEFICBOC-UHFFFAOYSA-N
• XLogP: 50.12
• TPSA: 97.06 Ų
• H-Bond Acceptors: 10
• Rotatable Bonds: 22
• Heavy Atoms: 200
• Complexity: —

Lipinski Rule of Five

2 violations

Rule	Value
MW ≤ 500	2549.17
LogP ≤ 5	50.12
H-Bond Donors ≤ 5	0
H-Bond Acceptors ≤ 10	10

Computed Properties (RDKit)

• Structural Alerts: {'alert_name': 'Polycyclic_aromatic_hydrocarbon_2', 'substructure': 'N/A'}

Frequently Asked Questions

What is the IUPAC name of 1-[4-[10-(2,5-diphenylphenyl)anthracen-9-yl]phenyl]-2-phenylbenzimidazole;1-[4-[10-(3,4-diphenylphenyl)anthracen-9-yl]phenyl]-2-phenylbenzimidazole;2-phenyl-1-[4-[10-(4-pyridin-3-ylphenyl)anthracen-9-yl]phenyl]benzimidazole;2-phenyl-1-[4-[10-(4-pyridin-4-ylphenyl)anthracen-9-yl]phenyl]benzimidazole?

The IUPAC name of 1-[4-[10-(2,5-diphenylphenyl)anthracen-9-yl]phenyl]-2-phenylbenzimidazole;1-[4-[10-(3,4-diphenylphenyl)anthracen-9-yl]phenyl]-2-phenylbenzimidazole;2-phenyl-1-[4-[10-(4-pyridin-3-ylphenyl)anthracen-9-yl]phenyl]benzimidazole;2-phenyl-1-[4-[10-(4-pyridin-4-ylphenyl)anthracen-9-yl]phenyl]benzimidazole (CID 158150561) is 1-[4-[10-(2,5-diphenylphenyl)anthracen-9-yl]phenyl]-2-phenylbenzimidazole;1-[4-[10-(3,4-diphenylphenyl)anthracen-9-yl]phenyl]-2-phenylbenzimidazole;2-phenyl-1-[4-[10-(4-pyridin-3-ylphenyl)anthracen-9-yl]phenyl]benzimidazole;2-phenyl-1-[4-[10-(4-pyridin-4-ylphenyl)anthracen-9-yl]phenyl]benzimidazole.

What is the SMILES notation for 1-[4-[10-(2,5-diphenylphenyl)anthracen-9-yl]phenyl]-2-phenylbenzimidazole;1-[4-[10-(3,4-diphenylphenyl)anthracen-9-yl]phenyl]-2-phenylbenzimidazole;2-phenyl-1-[4-[10-(4-pyridin-3-ylphenyl)anthracen-9-yl]phenyl]benzimidazole;2-phenyl-1-[4-[10-(4-pyridin-4-ylphenyl)anthracen-9-yl]phenyl]benzimidazole?

The canonical SMILES for 1-[4-[10-(2,5-diphenylphenyl)anthracen-9-yl]phenyl]-2-phenylbenzimidazole;1-[4-[10-(3,4-diphenylphenyl)anthracen-9-yl]phenyl]-2-phenylbenzimidazole;2-phenyl-1-[4-[10-(4-pyridin-3-ylphenyl)anthracen-9-yl]phenyl]benzimidazole;2-phenyl-1-[4-[10-(4-pyridin-4-ylphenyl)anthracen-9-yl]phenyl]benzimidazole is c1ccc(-c2ccc(-c3c4ccccc4c(-c4ccc(-n5c(-c6ccccc6)nc6ccccc65)cc4)c4ccccc34)cc2-c2ccccc2)cc1.c1ccc(-c2ccc(-c3ccccc3)c(-c3c4ccccc4c(-c4ccc(-n5c(-c6ccccc6)nc6ccccc65)cc4)c4ccccc34)c2)cc1.c1ccc(-c2nc3ccccc3n2-c2ccc(-c3c4ccccc4c(-c4ccc(-c5cccnc5)cc4)c4ccccc34)cc2)cc1.c1ccc(-c2nc3ccccc3n2-c2ccc(-c3c4ccccc4c(-c4ccc(-c5ccncc5)cc4)c4ccccc34)cc2)cc1.

What is the InChIKey of 1-[4-[10-(2,5-diphenylphenyl)anthracen-9-yl]phenyl]-2-phenylbenzimidazole;1-[4-[10-(3,4-diphenylphenyl)anthracen-9-yl]phenyl]-2-phenylbenzimidazole;2-phenyl-1-[4-[10-(4-pyridin-3-ylphenyl)anthracen-9-yl]phenyl]benzimidazole;2-phenyl-1-[4-[10-(4-pyridin-4-ylphenyl)anthracen-9-yl]phenyl]benzimidazole?

The InChIKey is FVBALGVEFICBOC-UHFFFAOYSA-N. The full InChI is InChI=1S/2C51H34N2.2C44H29N3/c1-4-16-35(17-5-1)41-33-30-39(34-46(41)36-18-6-2-7-19-36)50-44-24-12-10-22-42(44)49(43-23-11-13-25-45(43)50)37-28-31-40(32-29-37)53-48-27-15-14-26-47(48)52-51(53)38-20-8-3-9-21-38;1-4-16-35(17-5-1)39-30-33-41(36-18-6-2-7-19-36)46(34-39)50-44-24-12-10-22-42(44)49(43-23-11-13-25-45(43)50)37-28-31-40(32-29-37)53-48-27-15-14-26-47(48)52-51(53)38-20-8-3-9-21-38;1-2-11-33(12-3-1)44-46-40-18-8-9-19-41(40)47(44)35-26-24-32(25-27-35)43-38-16-6-4-14-36(38)42(37-15-5-7-17-39(37)43)31-22-20-30(21-23-31)34-13-10-28-45-29-34;1-2-10-34(11-3-1)44-46-40-16-8-9-17-41(40)47(44)35-24-22-33(23-25-35)43-38-14-6-4-12-36(38)42(37-13-5-7-15-39(37)43)32-20-18-30(19-21-32)31-26-28-45-29-27-31/h2*1-34H;2*1-29H.

What are the key properties of 1-[4-[10-(2,5-diphenylphenyl)anthracen-9-yl]phenyl]-2-phenylbenzimidazole;1-[4-[10-(3,4-diphenylphenyl)anthracen-9-yl]phenyl]-2-phenylbenzimidazole;2-phenyl-1-[4-[10-(4-pyridin-3-ylphenyl)anthracen-9-yl]phenyl]benzimidazole;2-phenyl-1-[4-[10-(4-pyridin-4-ylphenyl)anthracen-9-yl]phenyl]benzimidazole?

1-[4-[10-(2,5-diphenylphenyl)anthracen-9-yl]phenyl]-2-phenylbenzimidazole;1-[4-[10-(3,4-diphenylphenyl)anthracen-9-yl]phenyl]-2-phenylbenzimidazole;2-phenyl-1-[4-[10-(4-pyridin-3-ylphenyl)anthracen-9-yl]phenyl]benzimidazole;2-phenyl-1-[4-[10-(4-pyridin-4-ylphenyl)anthracen-9-yl]phenyl]benzimidazole has a molecular weight of 2549.17 g/mol, XLogP of 50.12, 22 rotatable bonds, 0 hydrogen bond donors, and 10 hydrogen bond acceptors.

Where does this data come from?

All data for 1-[4-[10-(2,5-diphenylphenyl)anthracen-9-yl]phenyl]-2-phenylbenzimidazole;1-[4-[10-(3,4-diphenylphenyl)anthracen-9-yl]phenyl]-2-phenylbenzimidazole;2-phenyl-1-[4-[10-(4-pyridin-3-ylphenyl)anthracen-9-yl]phenyl]benzimidazole;2-phenyl-1-[4-[10-(4-pyridin-4-ylphenyl)anthracen-9-yl]phenyl]benzimidazole is sourced from PubChem (CID 158150561), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).